SenesTech Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SenesTech stock.
View analyst ratings for SenesTech or view top-rated stocks.

Wall Street analysts have given SenesTech a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SenesTech wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

SenesTech saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 1,060,000 shares, an increase of 165.5% from the January 28th total of 399,200 shares. Based on an average trading volume of 812,800 shares, the short-interest ratio is presently 1.3 days. Currently, 15.7% of the shares of the company are short sold.
View SenesTech's Short Interest.

SenesTech is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for SenesTech.

SenesTech, Inc. (NASDAQ:SNES) issued its quarterly earnings results on Wednesday, November, 11th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.59) by $0.03. The business had revenue of $0.08 million for the quarter, compared to analyst estimates of $0.05 million. SenesTech had a negative net margin of 3,471.89% and a negative trailing twelve-month return on equity of 272.97%.
View SenesTech's earnings history.

SenesTech's stock was trading at $2.48 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SNES stock has decreased by 37.4% and is now trading at $1.5526.
View which stocks have been most impacted by COVID-19.

Shares of SenesTech reverse split on Wednesday, February 5th 2020. The 1-20 reverse split was announced on Tuesday, February 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 4th 2020. An investor that had 100 shares of SenesTech stock prior to the reverse split would have 5 shares after the split.

1 brokerages have issued twelve-month price objectives for SenesTech's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate SenesTech's share price to reach $4.00 in the next year. This suggests a possible upside of 157.6% from the stock's current price.
View analysts' price targets for SenesTech or view top-rated stocks among Wall Street analysts.

Some companies that are related to SenesTech include China Green Agriculture (CGA), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), China Agri-Business (CHBU), Igene Biotechnology (IGNE) and Nufarm Limited (NUF.AX) (NUF).
View all of SNES's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Auris Medical (EARS), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), McDermott International (MDR), ZIOPHARM Oncology (ZIOP), Catabasis Pharmaceuticals (CATB), Citius Pharmaceuticals (CTXR) and DURECT (DRRX).

(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNES stock can currently be purchased for approximately $1.55.

SenesTech has a market capitalization of $6.99 million and generates $140,000.00 in revenue each year. The company earns $-10,020,000.00 in net income (profit) each year or ($7.69) on an earnings per share basis.

SenesTech employs 34 workers across the globe.

The official website for SenesTech is www.senestech.com.

SenesTech is headquartered at 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027.

SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The company can be reached via phone at (928) 779-4143 or via email at [email protected]